201 related articles for article (PubMed ID: 23896422)
1. Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy.
Tchilian E; Ahuja D; Hey A; Jiang S; Beverley P
Vaccine; 2013 Sep; 31(41):4624-31. PubMed ID: 23896422
[TBL] [Abstract][Full Text] [Related]
2. Environmental effects on protection against Mycobacterium tuberculosis after immunization with Ad85A.
Beverley P; Ronan E; Lee L; Arnold I; Bolinger B; Powrie F; Tchilian E
Vaccine; 2013 Feb; 31(7):1086-93. PubMed ID: 23262169
[TBL] [Abstract][Full Text] [Related]
3. CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.
Lee LN; Ronan EO; de Lara C; Franken KL; Ottenhoff TH; Tchilian EZ; Beverley PC
Infect Immun; 2011 Aug; 79(8):3328-37. PubMed ID: 21628524
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen.
Santosuosso M; Zhang X; McCormick S; Wang J; Hitt M; Xing Z
J Immunol; 2005 Jun; 174(12):7986-94. PubMed ID: 15944305
[TBL] [Abstract][Full Text] [Related]
5. Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection.
Ronan EO; Lee LN; Beverley PC; Tchilian EZ
PLoS One; 2009 Dec; 4(12):e8235. PubMed ID: 20011050
[TBL] [Abstract][Full Text] [Related]
6. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
Goonetilleke NP; McShane H; Hannan CM; Anderson RJ; Brookes RH; Hill AV
J Immunol; 2003 Aug; 171(3):1602-9. PubMed ID: 12874255
[TBL] [Abstract][Full Text] [Related]
7. Using a prime and pull approach, lentivector vaccines expressing Ag85A induce immunogenicity but fail to induce protection against Mycobacterium bovis bacillus Calmette-Guérin challenge in mice.
Britton G; MacDonald DC; Brown JS; Collins MK; Goodman AL
Immunology; 2015 Oct; 146(2):264-70. PubMed ID: 26095282
[TBL] [Abstract][Full Text] [Related]
8. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
Radosevic K; Wieland CW; Rodriguez A; Weverling GJ; Mintardjo R; Gillissen G; Vogels R; Skeiky YA; Hone DM; Sadoff JC; van der Poll T; Havenga M; Goudsmit J
Infect Immun; 2007 Aug; 75(8):4105-15. PubMed ID: 17526747
[TBL] [Abstract][Full Text] [Related]
9. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R
Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020
[TBL] [Abstract][Full Text] [Related]
10. Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection.
Muflihah H; Flórido M; Lin LCW; Xia Y; Triccas JA; Stambas J; Britton WJ
Vaccine; 2018 Apr; 36(18):2462-2470. PubMed ID: 29602704
[TBL] [Abstract][Full Text] [Related]
11. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P
Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467
[TBL] [Abstract][Full Text] [Related]
12. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
[TBL] [Abstract][Full Text] [Related]
13. Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine.
Ronan EO; Lee LN; Tchilian EZ; Beverley PC
Vaccine; 2010 Jul; 28(32):5179-84. PubMed ID: 20558252
[TBL] [Abstract][Full Text] [Related]
14. Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice.
Todoroff J; Lemaire MM; Fillee C; Jurion F; Renauld JC; Huygen K; Vanbever R
PLoS One; 2013; 8(5):e63344. PubMed ID: 23675482
[TBL] [Abstract][Full Text] [Related]
15. Chemokine gene expression in lung CD8 T cells correlates with protective immunity in mice immunized intra-nasally with Adenovirus-85A.
Lee LN; Baban D; Ronan EO; Ragoussis J; Beverley PC; Tchilian EZ
BMC Med Genomics; 2010 Oct; 3():46. PubMed ID: 20942964
[TBL] [Abstract][Full Text] [Related]
16. Immunological characterization of chimeras of high specificity antigens from Mycobacterium tuberculosis H37Rv.
Fatma F; Tripathi DK; Srivastava M; Srivastava KK; Arora A
Tuberculosis (Edinb); 2021 Mar; 127():102054. PubMed ID: 33550109
[TBL] [Abstract][Full Text] [Related]
17. Heterologous priming-boosting immunization of cattle with Mycobacterium tuberculosis 85A induces antigen-specific T-cell responses.
Taracha EL; Bishop R; Musoke AJ; Hill AV; Gilbert SC
Infect Immun; 2003 Dec; 71(12):6906-14. PubMed ID: 14638779
[TBL] [Abstract][Full Text] [Related]
18. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.
Santosuosso M; McCormick S; Zhang X; Zganiacz A; Xing Z
Infect Immun; 2006 Aug; 74(8):4634-43. PubMed ID: 16861651
[TBL] [Abstract][Full Text] [Related]
19.
Clemmensen HS; Dube JY; McIntosh F; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Behr MA; Mortensen R
mBio; 2021 Apr; 12(2):. PubMed ID: 33879592
[TBL] [Abstract][Full Text] [Related]
20. Induction of an Immune-Protective T-Cell Repertoire With Diverse Genetic Coverage by a Novel Viral-Vectored Tuberculosis Vaccine in Humans.
Jeyanathan M; Damjanovic D; Yao Y; Bramson J; Smaill F; Xing Z
J Infect Dis; 2016 Dec; 214(12):1996-2005. PubMed ID: 27703038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
